| Spiritual care in the intensive care unit: a narrative review JQ Ho, CD Nguyen, R Lopes, SC Ezeji-Okoye, WG Kuschner Journal of intensive care medicine 33 (5), 279-287, 2018 | 98 | 2018 |
| COVID-19 and preexisting comorbidities: risks, synergies, and clinical outcomes B Bigdelou, MR Sepand, S Najafikhoshnoo, JAT Negrete, M Sharaf, ... Frontiers in immunology 13, 890517, 2022 | 74 | 2022 |
| Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy S Zanganeh, R Spitler, G Hutter, JQ Ho, M Pauliah, M Mahmoudi Immunotherapy 9 (10), 819-835, 2017 | 48 | 2017 |
| The immune response to COVID‐19: Does sex matter? JQ Ho, MR Sepand, B Bigdelou, T Shekarian, R Esfandyarpour, ... Immunology 166 (4), 429-443, 2022 | 29 | 2022 |
| Immunoengineering in glioblastoma imaging and therapy S Zanganeh, P Georgala, C Corbo, L Arabi, JQ Ho, N Javdani, ... Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 11 (6 …, 2019 | 20 | 2019 |
| Iron Oxide Nanoparticles for Biomedical Applications S Zanganeh, M Aieneravaie, M Erfanzadeh, J Ho, R Spitler Elsevier, 2018 | 14 | 2018 |
| Drug delivery systems: possibilities and challenges R Spitler, S Zanganeh, T Jafari, N Khakpash, M Erfanzadeh, JQ Ho, ... Drug Deliv. Syst, 1-52, 2017 | 14 | 2017 |
| Magnetic particle imaging (MPI) S Zanganeh, M Aieneravaie, M Erfanzadeh, JQ Ho, R Spitler Iron Oxide Nanoparticles for Biomedical Applications, 115-133, 2018 | 10 | 2018 |
| How do nanoparticles (NPs) pass barriers S Zanganeh, R Spitler, N Javdani, JQ Ho Drug delivery systems 1, 89, 2017 | 9 | 2017 |
| Ferroptosis: Environmental causes, biological redox signaling responses, cancer and other health consequences MR Sepand, B Bigdelou, AS Maghsoudi, N Sanadgol, JQ Ho, P Chauhan, ... Coordination Chemistry Reviews 480, 215024, 2023 | 8 | 2023 |
| Walking while talking in older adults with chronic kidney disease JQ Ho, J Verghese, MK Abramowitz Clinical journal of the American Society of Nephrology 15 (5), 665-672, 2020 | 8 | 2020 |
| Tumor-targeted therapy Iron oxide nanoparticles for biomedical applications M Pauliah, S Zanganeh, M Erfanzadeh, J Ho Elsevier, 2018 | 8* | 2018 |
| Long-term immunity and antibody response: challenges for developing efficient COVID-19 vaccines MR Sepand, B Bigdelou, JQ Ho, M Sharaf, AJ Lannigan, IM Sullivan, ... Antibodies 11 (2), 35, 2022 | 7 | 2022 |
| Drug delivery S Zanganeh, JQ Ho, M Aieneravaie, M Erfanzadeh, M Pauliah, R Spitler Iron Oxide Nanoparticles for Biomedical Applications, 247-271, 2018 | 7 | 2018 |
| Nanoparticles in circulation: blood stability S Zanganeh, T Jafari, N Khakpash, M Erfanzadeh, JQ Ho Drug delivery systems 1, 53, 2017 | 7 | 2017 |
| Nanotechnology and nanomedicine JQ Ho, L Arabi, M Basu, F Khaled, Y Gonzalez, D Ghegeliu, N Javdani, ... Nanomedicine for ischemic cardiomyopathy, 9-21, 2020 | 5 | 2020 |
| Protein corona: the challenge at the nanobiointerfaces S Zanganeh, JQ Ho, M Aieneravaie, M Erfanzadeh, R Spitler Iron Oxide Nanoparticles for Biomedical Applications, 91-104, 2018 | 4 | 2018 |
| Clinical Consequences of Metabolic Acidosis—Muscle JQ Ho, MK Abramowitz Advances in Chronic Kidney Disease 29 (4), 395-405, 2022 | 3 | 2022 |
| Nanocytotoxicity S Zanganeh, R Spitler, M Erfanzadeh, JQ Ho, M Aieneravaie Iron Oxide Nanoparticles for Biomedical Applications, 105-114, 2018 | 3 | 2018 |
| Cancer therapy S Zanganeh, JQ Ho, R Spitler, T Jafari, N Khakpash, M Erfanzadeh, ... Iron Oxide Nanoparticles for Biomedical Applications, 291-307, 2018 | 3 | 2018 |
